U.S. Packaging Stock News

OTCPK:MGTE
OTCPK:MGTEDiversified Financial

Marblegate Capital (OTCPK:MGTE) Revenue Decline Of 35.8% Tests Bullish Recovery Narratives

Marblegate Capital (OTCPK:MGTE) has just posted its FY 2025 numbers, reporting Q3 revenue of US$12.0 million and a basic EPS loss of US$0.02. This is set against a trailing 12 month revenue base of US$10.3 million and a basic EPS loss of US$0.91 that reflects the broader year. Over recent quarters, the company’s revenue has moved from US$5.1 million in Q2 2024 to US$5.4 million in Q3 2024 and then to US$4.6 million, US$9.7 million and US$12.0 million in Q1, Q2 and Q3 2025 respectively. EPS...
NasdaqCM:DERM
NasdaqCM:DERMPharmaceuticals

Journey Medical (DERM) Losses Narrow In Q4 EPS Result Tests Bullish Profitability Narrative

Journey Medical (DERM) closed FY 2025 with Q4 revenue of US$16.1 million and a basic EPS loss of US$0.05, while trailing twelve month figures show revenue of US$61.9 million and a basic EPS loss of US$0.47. Over recent quarters, revenue has ranged from US$13.1 million in Q1 2025 to US$17.6 million in Q3 2025, with basic EPS moving between a loss of US$0.18 and a loss of US$0.05. This sets up a story in which top line scale is building while margins remain under pressure. See our full analysis...
NasdaqCM:FXNC
NasdaqCM:FXNCBanks

First National (FXNC) Net Interest Margin Strengthens Bullish Narratives In FY 2025 Earnings

First National (FXNC) has reported FY 2025 results with fourth quarter revenue of US$23.0 million and EPS of US$0.61, capping a trailing twelve month revenue line of US$87.0 million and EPS of US$1.97 that reflects 154.1% earnings growth over the past year. Over recent periods, revenue has moved from US$13.3 million in Q3 2024 to US$17.1 million in Q4 2024 and then to US$23.0 million in Q4 2025. Quarterly EPS shifted from a loss of US$0.10 in Q4 2024 to US$0.61 in Q4 2025, highlighting a...
OTCPK:AMRQ.F
OTCPK:AMRQ.FMetals and Mining

Amaroq (OTCPK:AMRQ.F) Q3 Revenue Breakout Tests Bullish Growth Narrative Against Ongoing Losses

Amaroq Q3 2025 earnings snapshot Amaroq (OTCPK:AMRQ.F) has just reported Q3 2025 results with revenue of C$12.8 million and a basic EPS loss of C$0.0117, alongside trailing twelve month revenue of C$16.3 million and a basic EPS loss of C$0.0511. Over recent quarters the company has seen revenue move from C$0 in Q3 2024 to C$3.4 million in Q2 2025 and then to C$12.8 million in Q3 2025, while quarterly basic EPS has ranged between a loss of C$0.0428 and a loss of C$0.0111 across the same...
NasdaqGM:KALV
NasdaqGM:KALVBiotechs

KalVista Pharmaceuticals (KALV) Q4 Revenue Jump Tests Bullish Profitability Narrative

KalVista Pharmaceuticals (KALV) closed FY 2025 with fourth quarter revenue of US$59.9 million and a basic EPS loss of US$0.10, alongside net income excluding extra items of a US$5.4 million loss. This provides a clear snapshot of a business still in investment mode. The company has seen quarterly revenue shift from US$13.7 million in FY 2025 Q3 to US$59.9 million in FY 2025 Q4, while basic EPS moved from a US$0.92 loss to a US$0.10 loss over the same period, highlighting a set of results...
NasdaqGS:CZR
NasdaqGS:CZRHospitality

Caesars Bets On Vanderpump Hotel To Expand Non Gaming Appeal

Caesars Entertainment (NasdaqGS:CZR) is converting The Cromwell on the Las Vegas Strip into The Vanderpump Hotel. The new boutique property is positioned around Lisa Vanderpump's hospitality brand and design concepts. The launch introduces a non gaming focused draw within Caesars' broader Las Vegas portfolio. For Caesars Entertainment, the move fits with a broader shift in Las Vegas toward high profile branded hospitality concepts, where food, beverage and design carry as much weight as...
NasdaqGM:TMDX
NasdaqGM:TMDXMedical Equipment

TransMedics Expands OCS Program As Kidney And Lung Platform Story Grows

TransMedics Group expanded its National Organ Care System Program, aiming to handle a larger share of U.S. transplant procedures. The company is advancing kidney and lung transplant initiatives, including full control of the ENHANCE clinical trial. TransMedics is preparing simultaneous U.S. and Europe clinical trial launches for its kidney program as part of a broader transplant platform push. TransMedics Group, NasdaqGM:TMDX, is pushing beyond its medical device roots toward a more...
NYSE:PBT
NYSE:PBTOil and Gas

Permian Basin Royalty Trust Dividend Cut Highlights Income Variability Risks

Permian Basin Royalty Trust (NYSE:PBT) has announced a dividend decrease. The change affects upcoming distributions to unitholders and updates the trust's income profile. Permian Basin Royalty Trust holds royalty interests in oil and gas properties, so its cash distributions are closely tied to production volumes and commodity prices. A dividend adjustment like this can signal that recent cash receipts from underlying properties differ from prior periods. For income focused investors, the...
NYSE:VLO
NYSE:VLOOil and Gas

Valero Lawsuit Puts Port Arthur Explosion And Valuation In Focus

Valero Energy (NYSE:VLO) is facing a worker lawsuit that alleges negligence after the recent explosion at its Port Arthur refinery. The suit claims gross negligence related to safety practices and working conditions at one of Valero's largest facilities. This legal action adds fresh scrutiny to the company's operational risk management and potential liability exposure. Valero is one of the largest independent refiners in the US, with operations that supply transportation fuels and other...
NasdaqGM:CDNA
NasdaqGM:CDNABiotechs

Exploring 3 High Growth Tech Stocks in the US Market

Over the last 7 days, the United States market has remained flat, yet it has risen by 16% over the past year with expectations of earnings growing annually by a similar rate in the coming years. In this context of steady growth, identifying high growth tech stocks involves looking for companies that demonstrate strong innovation and potential to outperform these promising market conditions.
NasdaqGS:ASTS
NasdaqGS:ASTSTelecom

3 Stocks Trading Below Estimated Intrinsic Value By Up To 46.8%

In the last week, the United States market has stayed flat, although it is up 16% over the past year with earnings forecasted to grow by 16% annually. In this environment, identifying stocks trading below their estimated intrinsic value can present opportunities for investors seeking potential growth at a reasonable price.
NasdaqGS:CLNE
NasdaqGS:CLNEOil and Gas

Discovering Opportunities: Clean Energy Fuels And 2 Other Promising Penny Stocks

In the last week, the market has stayed flat, but over the past 12 months, it has risen by 16%, with earnings projected to grow annually at a similar rate. In light of these conditions, identifying stocks with solid fundamentals and growth potential is crucial for investors seeking opportunities. Penny stocks may be an outdated term, yet they represent a valuable investment area for those interested in smaller or newer companies that offer affordability and potential upside when backed by...
NYSE:VTOL
NYSE:VTOLEnergy Services

US Market's Hidden Treasures: 3 Undiscovered Gems to Consider

In the last week, the United States market has remained flat, though it has risen by 16% over the past year with earnings expected to grow annually at the same rate. In this environment, identifying stocks with strong fundamentals and growth potential can offer investors opportunities to uncover hidden treasures in a dynamic market landscape.
NYSE:EGY
NYSE:EGYOil and Gas

A Look At VAALCO Energy’s Valuation After Weak 2025 Results And New 2026 Production Guidance

VAALCO Energy (EGY) is on investors’ radar after releasing fourth quarter and full year 2025 results that showed a shift to a net loss, lower production volumes, and fresh 2026 production guidance. See our latest analysis for VAALCO Energy. The earnings miss and 2026 production guidance have arrived against a backdrop of strong momentum, with a 30 day share price return of 22.42% and a 1 year total shareholder return of 71.16%. This suggests sentiment has strengthened recently despite weaker...
NYSE:ALIT
NYSE:ALITProfessional Services

Assessing Alight’s Valuation As Lawsuit Fallout, Dividend Cut And Weak Results Pressure The Share Price

Alight (ALIT) is back in focus after investors filed a class action lawsuit alleging the company misled the market on growth prospects and financial stability, ahead of disappointing results, a dividend cancellation, and higher compensation expenses. See our latest analysis for Alight. The legal action and dividend cancellation have coincided with sharp share price pressure, with a 1 day share price return showing a 16.24% decline and a 1 year total shareholder return showing a 91.01% loss,...
NYSE:WS
NYSE:WSMetals and Mining

Undervalued Small Caps With Insider Action To Watch In March 2026

In the last week, the United States market has remained flat, but over the past 12 months, it has experienced a notable rise of 16%, with earnings projected to grow by another 16% annually. In this context of steady growth and future potential, identifying small-cap stocks that appear undervalued and exhibit insider activity can offer intriguing opportunities for investors seeking to navigate these dynamic market conditions.
NasdaqGS:LITE
NasdaqGS:LITECommunications

3 Stocks Estimated To Be Up To 38.3% Below Intrinsic Value

Over the last 7 days, the United States market has remained flat, yet it is up 16% over the past year with earnings expected to grow by 16% annually in the coming years. In this context, identifying undervalued stocks—those trading below their intrinsic value—can present potential opportunities for investors looking to capitalize on future growth.
NasdaqGS:RDWR
NasdaqGS:RDWRSoftware

US Undiscovered Gems To Explore In March 2026

The United States market has remained flat over the last week but is up 16% over the past year, with earnings forecasted to grow by 16% annually. In this environment, identifying stocks that have yet to capture widespread attention can offer unique opportunities for investors seeking growth potential amidst steady market conditions.